News

News and publications from PhaRegistrum on pharmaceutical consultancy, regulatory affairs and our sectors of activity.

Publication archive

PhaRegistrum publications translated into English, preserving the original date and source.

Page 3 of 5

Biocides regulation: do you need specialist support?

The legal framework for biocidal products is technical, demanding and constantly evolving. From regulatory strategy to product authorisation, every stage requires specialist knowledge.PhaRegistrum provides comprehensive support for biocides regulatory procedures (PT1–PT22) under…

Read publication

Mandatory EUDAMED use is approaching

From 28 May 2026, use of the following modules will be mandatory:Actor registration.Device/UDI registration.Notified bodies and certificates.Market surveillance.Without economic operator registration, the other modules cannot be used.Non-compliance may result in marketing restrictions,…

Read publication

SIEXP portal update: remember your obligations

Under the regulation on medicine availability management, wholesale distributors and manufacturers must report exported medicines, quantities and destination countries through INFARMED’s SIEXP portal.Reporting deadlines: 15 January, 15 April, 15 July and 15…

Read publication

Happy Easter 2026 from PhaRegistrum

Easter invites us to recharge and value what truly matters: trust, collaboration and purpose. 🌼✨May these days bring peace, motivation and joy to everyone who shares our journey. May Easter symbolise togetherness…

Read publication

New medicinal gases regulation is now in force

Decision No. 1425/2025 entered into force on 2 December 2025, replacing the previous regulation and clarifying every stage of the medicinal gases lifecycle: manufacture, authorisation, premises and equipment, labelling and leaflets, traceability,…

Read publication